157 related articles for article (PubMed ID: 34032953)
21. The Use of Long-Acting Injectable Antipsychotics (LAI) in the Serious Mental Illness (SMI) Patients Enrolled in an Assertive Community Treatment (ACT) Program.
Yee MR; Espiridon E; Oladunjoye AO; Millsaps U; Vora A; Harvey N
Cureus; 2021 Apr; 13(4):e14490. PubMed ID: 34007745
[TBL] [Abstract][Full Text] [Related]
22. [Efficacy of the "VADO" approach in psychiatric rehabilitation: a controlled study].
Vittorielli M; Pioli R; Brambilla L; Archiati L; Rossi G; Sleijpen C; Magliano L; Veltro F; Morosini P
Epidemiol Psichiatr Soc; 2003; 12(1):43-52. PubMed ID: 12723391
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of Postacute Neuropsychological Rehabilitation for Patients with Acquired Brain Injuries is Maintained in the Long-Term.
Shany-Ur T; Bloch A; Salomon-Shushan T; Bar-Lev N; Sharoni L; Hoofien D
J Int Neuropsychol Soc; 2020 Jan; 26(1):130-141. PubMed ID: 31983377
[TBL] [Abstract][Full Text] [Related]
24. An extended stroke rehabilitation service for people who have had a stroke: the EXTRAS RCT.
Shaw L; Bhattarai N; Cant R; Drummond A; Ford GA; Forster A; Francis R; Hills K; Howel D; Laverty AM; McKevitt C; McMeekin P; Price C; Stamp E; Stevens E; Vale L; Rodgers H
Health Technol Assess; 2020 May; 24(24):1-202. PubMed ID: 32468989
[TBL] [Abstract][Full Text] [Related]
25. Outcome assessment of the VADO approach in psychiatric rehabilitation: a partially randomised multicentric trial.
Pioli R; Vittorielli M; Gigantesco A; Rossi G; Basso L; Caprioli C; Buizza C; Corradi A; Mirabella F; Morosini P; Falloon IR
Clin Pract Epidemiol Ment Health; 2006 Apr; 2():5. PubMed ID: 16584543
[TBL] [Abstract][Full Text] [Related]
26. [Difficult-to-engage patients: What evolution after discharge from Assertive Community Programs?].
Vidal S; Correa L; Perroud N; Huguelet P
Encephale; 2021 Oct; 47(5):426-434. PubMed ID: 33648751
[TBL] [Abstract][Full Text] [Related]
27. Evidence-Based Expert Consensus Regarding Long-Acting Injectable Antipsychotics for Schizophrenia from the Taiwanese Society of Biological Psychiatry and Neuropsychopharmacology (TSBPN).
Yang KC; Liao YT; Yang YK; Lin SK; Liang CS; Bai YM
CNS Drugs; 2021 Aug; 35(8):893-905. PubMed ID: 34312788
[TBL] [Abstract][Full Text] [Related]
28. Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis.
Lin D; Thompson-Leduc P; Ghelerter I; Nguyen H; Lafeuille MH; Benson C; Mavros P; Lefebvre P
CNS Drugs; 2021 May; 35(5):469-481. PubMed ID: 33909272
[TBL] [Abstract][Full Text] [Related]
29. Evidence-based treatment for schizophrenia.
Lehman AF; Buchanan RW; Dickerson FB; Dixon LB; Goldberg R; Green-Paden L; Kreyenbuhl J
Psychiatr Clin North Am; 2003 Dec; 26(4):939-54. PubMed ID: 14711129
[TBL] [Abstract][Full Text] [Related]
30. Three-Year Naturalistic Study On Early Use Of Long-Acting Injectable Antipsychotics In First Episode Psychosis.
Medrano S; Abdel-Baki A; Stip E; Potvin S
Psychopharmacol Bull; 2018 Jun; 48(4):25-61. PubMed ID: 30618474
[TBL] [Abstract][Full Text] [Related]
31. Feasibility and outcomes of paid undergraduate student nurse positions.
Gamroth L; Budgen C; Lougheed M
Nurs Leadersh (Tor Ont); 2006 Sep; 19(3):e1-14. PubMed ID: 19830923
[TBL] [Abstract][Full Text] [Related]
32. An empirical evaluation of recovery transformation at a large community psychiatric rehabilitation organization.
Malinovsky I; Lehrer P; Silverstein SM; Shankman SA; O'Brien W; Samuelson T; van Nostrand G
Psychol Serv; 2013 Nov; 10(4):428-41. PubMed ID: 23815360
[TBL] [Abstract][Full Text] [Related]
33. Assessing the comparative effectiveness of long-acting injectable vs. oral antipsychotic medications in the prevention of relapse provides a case study in comparative effectiveness research in psychiatry.
Kane JM; Kishimoto T; Correll CU
J Clin Epidemiol; 2013 Aug; 66(8 Suppl):S37-41. PubMed ID: 23849151
[TBL] [Abstract][Full Text] [Related]
34. Comparative effectiveness of long-acting risperidone in New Zealand: a report of resource utilization and costs in a 12-month mirror-image analysis.
Carswell C; Wheeler A; Vanderpyl J; Robinson E
Clin Drug Investig; 2010; 30(11):777-87. PubMed ID: 20712387
[TBL] [Abstract][Full Text] [Related]
35. [Diagnostic structured interviews in child and adolescent's psychiatry].
Renou S; Hergueta T; Flament M; Mouren-Simeoni MC; Lecrubier Y
Encephale; 2004; 30(2):122-34. PubMed ID: 15107714
[TBL] [Abstract][Full Text] [Related]
36. Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder.
Greene M; Yan T; Chang E; Hartry A; Touya M; Broder MS
J Med Econ; 2018 Feb; 21(2):127-134. PubMed ID: 28895758
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of psychosocial treatments on symptoms and functional domains in schizophrenia spectrum disorders: a prospective study in a real-world setting.
Bozzatello P; Bellino S; De Marzi G; Macrì A; Piterà R; Montemagni C; Rocca P
Disabil Rehabil; 2019 Nov; 41(23):2799-2806. PubMed ID: 29986607
[No Abstract] [Full Text] [Related]
38. Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: a cluster randomised controlled trial with integral process and economic evaluation - the CASCADE study.
Christie D; Thompson R; Sawtell M; Allen E; Cairns J; Smith F; Jamieson E; Hargreaves K; Ingold A; Brooks L; Wiggins M; Oliver S; Jones R; Elbourne D; Santos A; Wong IC; O'Neill S; Strange V; Hindmarsh P; Annan F; Viner R
Health Technol Assess; 2014 Mar; 18(20):1-202. PubMed ID: 24690402
[TBL] [Abstract][Full Text] [Related]
39. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
[TBL] [Abstract][Full Text] [Related]
40. Effects of the Personalized Recovery Oriented Services (PROS) Program on Hospitalizations.
White C; Frimpong E; Huz S; Ronsani A; Radigan M
Psychiatr Q; 2018 Jun; 89(2):261-271. PubMed ID: 28971347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
